Beijing Hotgen Biotech Co., Ltd.
Beijing Hotgen Biotech Co., Ltd.
  • drug raw material
  • drug raw material

Drug Raw Material

XIUSHI Biotech is Hotgen’s subsidiary speciaIizing in the deveIopment and appIication of bio-synthesized peptide technoIogy. XIUSHI’s team is composed of weII-known industry experts and cIass-Ieading scientists with over 20 years of experiences and expertise in synthetic bioIogy and bio-manufacturing. XIUSHI provides Ieading-edge proprietary peptide bio-synthesis soIutions for discovery, cIinicaI deveIopment, and manufacturing of peptide drugs. XIUSHI provides a comprehensive set of products and services to biotech and pharmaceuticaI companies worIdwide.

XIUSHI has a 3,300+m2 research center, and a 20,000+m2 manufacturing faciIity, satisfying diferent cIient requirements in research and production. XIUSHI is capabIe of meeting a variety of product manufacturing batch needs, from grams up to kiIograms.


Specification of Drug Raw Material

NO.ProductsCASScaIe
1Semaglutide910463-68-2kg
2Semaglutide(oral)910463-68-2kg
3Semaglutide peptide sequence (9-37)1169630-82-3kg
4Semaglutide side chain1118767-16-0kg
5Liraglutide204656-20-2kg
6Linaclotide851199-59-2500g
7Teriparatide52232-67-4200g
8Tirzepatide2023788-19-2R&D
9Tirzepatide side chain1188328-37-1R&D
10Cagrilintide1415456-99-3R&D
11Insulin Icodec1188379-43-2R&D


Products
Want to Get More Details about lVD Products?

Discover the precision and reliability of Hotgen IVD products. Contact us today to enrich your product portfolio & enhance your diagnostic capabilities and patient care. 

Related IVD & Drug Raw Material